Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Ritlecitinib was generally well tolerated in children with alopecia areata.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

CTP-543 is generally safe for treating alopecia areata.

The combination treatment showed a higher response rate but no significant survival benefits.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Baricitinib is effective and safe for treating severe alopecia areata.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Baricitinib significantly improves hair regrowth in severe alopecia areata.